Cargando…
Prevalence of HIV Transmitted Drug Resistance in Nanjing from 2018 to 2021
BACKGROUND: Transmitted drug resistance (TDR) is a major challenge in the clinical management of acquired immunodeficiency syndrome (AIDS). Therefore, this study aimed to investigate the epidemic characteristics of and risk factors for human immunodeficiency virus (HIV)-1 TDR in Nanjing from 2018 to...
Autores principales: | Su, Yifan, Qi, Mingxue, Zhong, Mingli, Yu, Nawei, Chen, Chen, Ye, Zi, Cheng, Cong, Hu, Zhiliang, Zhang, Hongying, Wei, Hongxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901445/ https://www.ncbi.nlm.nih.gov/pubmed/36756611 http://dx.doi.org/10.2147/IDR.S391296 |
Ejemplares similares
-
A retrospective clinical study of dolutegravir- versus efavirenz-based regimen in treatment-naïve patients with advanced HIV infection in Nanjing, China
por: Zhong, Mingli, et al.
Publicado: (2023) -
Pre-existing low-frequency resistance mutations increase the risk of antiretroviral treatment failure in HIV-1 naïve patients
por: Su, Yifan, et al.
Publicado: (2023) -
Transmitted drug resistance and transmission clusters among ART-naïve HIV-1-infected individuals from 2019 to 2021 in Nanjing, China
por: Xu, Yuanyuan, et al.
Publicado: (2023) -
Antibiotic resistance of Helicobacter pylori isolated from patients in Nanjing, China: A cross-section study from 2018 to 2021
por: Jiang, Zongdan, et al.
Publicado: (2022) -
Survival and risk factors associated with mortality in people living with HIV from 2005 to 2018 in Nanjing, China
por: Zhu, Zhengping, et al.
Publicado: (2022)